Patents Assigned to Amorcyte, Inc.
  • Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
    Patent number: 9534202
    Abstract: The described invention provides methods and regimens for treating adverse consequences of a persistent and progressive myocardial injury-due to a vascular insufficiency that occurs early or late in a subject in need thereof, and progressive myocardial injury-preventing compositions that contain a chemotactic hematopoietic stem cell product, and, optionally, an additional active agent.
    Type: Grant
    Filed: October 31, 2011
    Date of Patent: January 3, 2017
    Assignee: Amorcyte, Inc.
    Inventors: Andrew L. Pecora, Robert A. Preti
  • Compositions and methods of vascular injury repair
    Patent number: 8709403
    Abstract: The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of CD34+/CXCR-4+ cells having CXCR-4-mediated chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: April 29, 2014
    Assignee: Amorcyte, Inc.
    Inventors: Andrew L. Pecora, Robert A. Preti
  • Compositions and methods of vascular injury repair
    Patent number: 8637005
    Abstract: The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of CD34+/CXCR-4+ cells having CXCR-4-mediated chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: January 28, 2014
    Assignee: Amorcyte, Inc.
    Inventors: Andrew L. Pecora, Robert A. Preti
  • COMPOSITIONS AND METHODS OF VASCULAR INJURY REPAIR
    Publication number: 20130121971
    Abstract: The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of CD34+/CXCR-4+ cells having CXCR-4-mediated chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.
    Type: Application
    Filed: November 27, 2012
    Publication date: May 16, 2013
    Applicant: AMORCYTE, INC.
    Inventor: Amorcyte, Inc.
  • Compositions and methods of vascular injury repair
    Patent number: 8343485
    Abstract: The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of CD34+/CXCR-4+ cells having CXCR-4-mediated chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.
    Type: Grant
    Filed: December 6, 2011
    Date of Patent: January 1, 2013
    Assignee: Amorcyte, Inc.
    Inventors: Andrew L. Pecora, Robert A. Preti
  • Compositions and methods of vascular injury repair
    Patent number: 8088370
    Abstract: The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of cells having chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: January 3, 2012
    Assignee: Amorcyte, Inc.
    Inventors: Andrew Pecora, Robert Preti
  • Compositions and methods of vascular injury repair
    Patent number: 7794705
    Abstract: The present invention relates to pharmaceutical compositions comprising a chemotactic hematopoietic stem cell product comprising an enriched population of CD34+ cells containing a subpopulation of cells having chemotactic activity, methods of preparing these compositions and use of these compositions to treat or repair vascular injury, including infarcted myocardium.
    Type: Grant
    Filed: October 24, 2006
    Date of Patent: September 14, 2010
    Assignee: Amorcyte, Inc.
    Inventors: Andrew L. Pecora, Robert A. Preti